P14ARF induces apoptosis via an entirely caspase-3-dependent mitochondrial amplification loop

International Journal of Cancer

Volumn 133, Issue 11, 2013, Pages 2551-2562

  Milojkovic, Ana ^a   Hemmati, Philipp G ^a   Müer, Annika ^a   Overkamp, Tim ^a   Chumduri, Cindrilla ^a   Jänicke, Reiner U ^b   Gillissen, Bernd ^a   Daniel, Peter T ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

apoptosis; caspase 3; mitochondria; p14ARF

Indexed keywords

CASPASE 3; CYTOCHROME C; PROTEIN P14; PROTEIN P14 ARF; PROTEIN P53; UNCLASSIFIED DRUG; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEEDBACK SYSTEM; FUNCTIONAL ASSESSMENT; G1 PHASE CELL CYCLE CHECKPOINT; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MITOSIS; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; BREAST TUMOR; CELL CYCLE CHECKPOINT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MCF 7 CELL LINE; METABOLISM; CELL STRAIN MCF 7; P14ARF;

APOPTOSIS; BREAST NEOPLASMS; CASPASE 3; CELL CYCLE CHECKPOINTS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MITOCHONDRIA; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P14ARF;

APOPTOSIS; CASPASE-3; MITOCHONDRIA; P14ARF;

EID: 84884909671     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28279     Document Type: Article

References (47)

1. Duro D, Bernard O, Della Valle V, et al. A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies. Oncogene 1995; 11: 21-9.
2. Mao L, Merlo A, Bedi G, et al. A novel p16INK4A transcript. Cancer Res 1995; 55: 2995-7.
3. Stone S, Jiang P, Dayananth P, et al. Complex structure and regulation of the P16 (MTS1) locus. Cancer Res 1995; 55: 2988-94.
4. Quelle DE, Cheng M, Ashmun RA, et al. Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF. Proc Natl Acad Sci USA 1997; 94: 669-73.
5. de Stanchina E, McCurrach ME, Zindy F, et al. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev 1998; 12: 2434-42.
6. Radfar A, Unnikrishnan I, Lee HW, et al. p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation. Proc Natl Acad Sci USA 1998; 95: 13194-9.
7. Zindy F, Eischen CM, Randle DH, et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev 1998; 12: 2424-33.
8. Sherr CJ,. Principles of tumor suppression. Cell 2004; 116: 235-46.
9. Korgaonkar C, Zhao L, Modestou M, et al. ARF function does not require p53 stabilization or Mdm2 relocalization. Mol Cell Biol 2002; 22: 196-206.
10. Yarbrough WG, Bessho M, Zanation A, et al. Human tumor suppressor ARF impedes S-phase progression independent of p53. Cancer Res 2002; 62: 1171-7.
11. Eymin B, Leduc C, Coll JL, et al. p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice. Oncogene 2003; 22: 1822-35.
12. Qi Y, Gregory MA, Li Z, et al. p19ARF directly and differentially controls the functions of c-Myc independently of p53. Nature 2004; 431: 712-17.
13. Hemmati PG, Gillissen B, von, Haefen C, et al. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis. Oncogene 2002; 21: 3149-61.
14. Hemmati PG, Normand G, Gillissen B, et al. Cooperative effect of p21Cip1/WAF-1 and 14-3-3sigma on cell cycle arrest and apoptosis induction by p14ARF. Oncogene 2008; 27: 6707-19.
15. Hemmati PG, Normand G, Verdoodt B, et al. Loss of p21 disrupts p14 ARF-induced G1 cell cycle arrest but augments p14 ARF-induced apoptosis in human carcinoma cells. Oncogene 2005; 24: 4114-28.
16. Rocha S, Campbell KJ, Perkins ND,. p53- and Mdm2-independent repression of NF-kappa B transactivation by the ARF tumor suppressor. Mol Cell 2003; 12: 15-25.
17. Eymin B, Claverie P, Salon C, et al. p14ARF triggers G2 arrest through ERK-mediated Cdc25C phosphorylation, ubiquitination and proteasomal degradation. Cell Cycle 2006; 5: 759-65.
18. Sherr CJ,. Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 2006; 6: 663-73.
19. Normand G, Hemmati PG, Verdoodt B, et al. p14ARF induces G2 cell cycle arrest in p53- and p21-deficient cells by down-regulating p34cdc2 kinase activity. J Biol Chem 2005; 280: 7118-30.
20. Bhonde MR, Hanski ML, Notter M, et al. Equivalent effect of DNA damage-induced apoptotic cell death or long-term cell cycle arrest on colon carcinoma cell proliferation and tumour growth. Oncogene 2006; 25: 165-75.
21. Rau B, Sturm I, Lage H, et al. Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy. J Clin Oncol 2003; 21: 3391-401.
22. Gillissen B, Essmann F, Graupner V, et al. Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway. EMBO J 2003; 22: 3580-90.
23. von Haefen C, Gillissen B, Hemmati PG, et al. Multidomain Bcl-2 homolog Bax but not Bak mediates synergistic induction of apoptosis by TRAIL and 5-FU through the mitochondrial apoptosis pathway. Oncogene 2004; 23: 8320-32.
24. Eymin B, Claverie P, Salon C, et al. p14ARF activates a Tip60-dependent and p53-independent ATM/ATR/CHK pathway in response to genotoxic stress. Mol Cell Biol 2006; 26: 4339-50.
25. Jänicke RU, Sprengart ML, Wati MR, et al. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 1998; 273: 9357-60.
26. Friedrich K, Wieder T, Von Haefen C, et al. Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance. Oncogene 2001; 20: 2749-60.
27. Craig C, Kim M, Ohri E, et al. Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells. Oncogene 1998; 16: 265-72.
28. Blanc C, Deveraux QL, Krajewski S, et al. Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells. Cancer Res 2000; 60: 4386-90.
29. Hemmati PG, Müer A, Gillissen B, et al. Systematic genetic dissection of p14ARF-mediated mitochondrial cell death signaling reveals a key role for p21CDKN1 and the BH3-only protein Puma/bbc3. J Mol Med 2010; 88: 609-22.
30. Wendt J, Radetzki S, von Haefen C, et al. Induction of p21CIP/WAF-1 and G2 arrest by ionizing irradiation impedes caspase-3-mediated apoptosis in human carcinoma cells. Oncogene 2006; 25: 972-80.
31. Jänicke RU, Ng P, Sprengart ML, et al. Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J Biol Chem 1998; 273: 15540-5.
32. Neise D, Graupner V, Gillissen BF, et al. Activation of the mitochondrial death pathway is commonly mediated by a preferential engagement of Bak. Oncogene 2008; 27: 1387-96.
33. Eymin B, Karayan L, Seite P, et al. Human ARF binds E2F1 and inhibits its transcriptional activity. Oncogene 2001; 20: 1033-41.
34. Martelli F, Hamilton T, Silver DP, et al. p19ARF targets certain E2F species for degradation. Proc Natl Acad Sci USA 2001; 98: 4455-60.
35. Mason SL, Loughran O, La Thangue NB,. p14(ARF) regulates E2F activity. Oncogene 2002; 21: 4220-30.
36. Rowland BD, Denissov SG, Douma S, et al. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest. Cancer Cell 2002; 2: 55-65.
37. Bunz F, Hwang PM, Torrance C, et al. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest 1999; 104: 263-9.
38. Waldman T, Lengauer C, Kinzler KW, et al. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 1996; 381: 713-16.
39. Yu J, Wang Z, Kinzler KW, et al. PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci USA 2003; 100: 1931-6.
40. Hemmati PG, Güner D, Gillissen B, et al. Bak functionally complements for loss of Bax during p14ARF-induced mitochondrial apoptosis in human cancer cells. Oncogene 2006; 25: 6582-94.
41. Muer A, Overkamp T, Gillissen B, et al. p14ARF-induced Apoptosis in p53 protein-deficient cells Is mediated by BH3-only protein-independent derepression of Bak protein through down-regulation of Mcl-1 and Bcl-xL proteins. J Biol Chem 2012; 287: 17343-52.
42. Enoksson M, Robertson JD, Gogvadze V, et al. Caspase-2 permeabilizes the outer mitochondrial membrane and disrupts the binding of cytochrome c to anionic phospholipids. J Biol Chem 2004; 279: 49575-8.
43. Vakifahmetoglu-Norberg H, Zhivotovsky B,. The unpredictable caspase-2: what can it do? Trends Cell Biol 2010; 20: 150-9.
44. Olsson M, Vakifahmetoglu H, Abruzzo PM, et al. DISC-mediated activation of caspase-2 in DNA damage-induced apoptosis. Oncogene 2009; 28: 1949-59.
45. Desagher S, Osen-Sand A, Nichols A, et al. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 1999; 144: 891-901.
46. Cartron PF, Juin P, Oliver L, et al. Nonredundant role of Bax and Bak in Bid-mediated apoptosis. Mol Cell Biol 2003; 23: 4701-12.
47. Willis SN, Fletcher JI, Kaufmann T, et al. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 2007; 315: 856-9.